DLK1 Gene

DLK1 Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Delta Like Non-Canonical Notch Ligand 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>DLK1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Delta Like Non-Canonical Notch Ligand 1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>14q32.12</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[1749](https://www.ncbi.nlm.nih.gov/gene/1749)</td></tr>
<tr><td><strong>OMIM</strong></td><td>176290</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000176358</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[O00548](https://www.uniprot.org/uniprot/O00548)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Epidermal Growth Factor Family</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), Cancer, Angelman Syndrome</td></tr>
</table>
</div>

Overview

DLK1 Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Delta Like Non-Canonical Notch Ligand 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>DLK1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Delta Like Non-Canonical Notch Ligand 1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>14q32.12</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[1749](https://www.ncbi.nlm.nih.gov/gene/1749)</td></tr>
<tr><td><strong>OMIM</strong></td><td>176290</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000176358</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[O00548](https://www.uniprot.org/uniprot/O00548)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Epidermal Growth Factor Family</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), Cancer, Angelman Syndrome</td></tr>
</table>
</div>

Overview

DLK1 (Delta-Like 1 Homolog), also known as PREF-1 (Pre-Adipocyte Factor 1), is a member of the epidermal growth factor (EGF)-like family that functions as a non-canonical Notch ligand and regulator of cell fate decisions. Located on chromosome 14q32.12 with NCBI Gene ID 1749, DLK1 is an imprinted gene expressed exclusively from the paternal allele["@baladron2002"][@laborda2016].

DLK1 has garnered attention in neurobiology due to its critical roles in neural development, synaptic plasticity, and potential involvement in neurodegenerative diseases. The protein functions as both a signaling molecule and a regulated protease substrate, producing soluble fragments that have distinct biological activities["@sul2004"][@evangelisti2009].

Gene and Protein Structure

Gene Organization

The DLK1 gene spans approximately 16 kb on chromosome 14q32.12 within a imprinted domain and consists of 8 exons. The gene produces multiple transcript variants encoding proteins of varying lengths, with the major isoform being a 396-amino acid transmembrane protein.

Protein Architecture

The DLK1 protein exhibits characteristic EGF-family architecture:

• N-terminal signal peptide: Directs secretion
• Multiple EGF-like repeats: Six EGF-like domains in the extracellular region
• Notch-binding domain: Mediates interactions with Notch receptors
• Transmembrane domain: Single pass membrane protein
• Cytoplasmic tail: Short intracellular domain with signaling motifs

Proteolytic Processing

DLK1 undergoes extensive proteolytic processing:

• ADAMTS cleavage: Metalloprotease cleavage releases soluble DLK1
• Gamma-secretase cleavage: Produces intracellular domain
• Alternative splicing: Generates multiple isoforms

Expression Pattern

Tissue Distribution

DLK1 exhibits specific expression patterns:

| Tissue | Expression Level | Function |
|--------|------------------|----------|
| Brain | High | Neurodevelopment, plasticity |
| Adrenal gland | High | Neuroendocrine function |
| Adipose tissue | Moderate | Adipogenesis inhibition |
| Muscle | Moderate | Regeneration |
| Liver | Low | Metabolic regulation |

Brain Expression

In the central nervous system, DLK1 is expressed in:

• Neural stem cells: Self-renewal regulation
• Neurons: Synaptic function
• Astrocytes: Glial support
• Subventricular zone: Neurogenesis
• Hippocampus: Plasticity and memory

Physiological Functions

Notch Signaling Regulation

DLK1 functions as a Notch ligand[@baladron2002][@rossi2014]:

• Non-canonical signaling: Unlike Delta, activates alternative pathways
• Notch inhibition: Can antagonize canonical Notch signaling
• Delta-like competition: Modulates Notch receptor activation
• Signal interpretation: Influences cell fate decisions

Cell Fate Determination

DLK1 controls cell fate in multiple contexts[@sul2004]:

• Neural stem cells: Maintains undifferentiated state
• Adipogenesis: Inhibits pre-adipocyte differentiation
• Myogenesis: Regulates muscle differentiation
• Neurogenesis: Promotes neuronal differentiation

Neurodevelopment

DLK1 plays critical roles in brain development[@evangelisti2009]:

• Neural stem cell maintenance: Prevents premature differentiation
• Neuronal differentiation: Promotes neuronal commitment
• Synaptogenesis: Regulates synapse formation
• Glial differentiation: Influences astrocyte lineage

Synaptic Plasticity

DLK1 is implicated in synaptic function[@mendez2018]:

• Memory formation: Required for hippocampal plasticity
• Synaptic strength: Modulates synaptic efficacy
• Activity-dependent expression: Regulated by neuronal activity

Role in Neurodegenerative Diseases

Alzheimer's Disease

DLK1 has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis[@fayed2017][@schröder2018]:

Expression Changes

• Altered expression: DLK1 levels changed in AD brain
• Neuronal loss: Associated with neurodegeneration
• Plaque association: Found in amyloid plaques

Potential Mechanisms

• Notch dysregulation: Altered Notch signaling in AD
• Neurogenesis impairment: Affects adult neurogenesis
• Synaptic dysfunction: Contributes to synaptic loss

Other Neurological Conditions

DLK1 has been studied in:

| Condition | Finding |
|-----------|---------|
| Parkinson's Disease | Altered expression in substantia nigra |
| Multiple Sclerosis | Impaired remyelination |
| Brain Aging | Declines with age |
| Neuroinflammation | Regulates microglial function |

Therapeutic Implications

Biomarker Potential

DLK1 shows potential as a biomarker:

• Serum levels: Detectable in blood
• Brain expression: Changes in disease states
• CSF levels: Potential for neurological assessment

Therapeutic Targets

Targeting DLK1 could provide benefits:

| Approach | Rationale | Status |
|----------|-----------|--------|
| Antibody therapy | Neutralize soluble DLK1 | Preclinical |
| Gene therapy | Modulate expression | Experimental |
| Small molecules | Inhibit proteolytic processing | Early development |

Interaction Network

Signaling Pathways

DLK1 interacts with:

• Notch receptors: Notch1, Notch2, Notch3
• ADAMTS proteases: ADAMTS1, ADAMTS5
• Gamma-secretase: Presenilin complex
• EGF family: Other EGF-like proteins

Cellular Functions

DLK1 affects:

• Cell cycle: Regulates proliferation
• Apoptosis: Modulates cell survival
• Differentiation: Controls lineage commitment
• Migration: Affects cell motility

Research Methods

Detection Techniques

• Immunohistochemistry: Tissue localization
• Western blot: Protein expression
• qPCR: mRNA analysis
• ELISA: Quantification in fluids

Model Systems

• Cell lines: Neural stem cells, neurons
• Animal models: Knockout mice
• Patient samples: Brain tissue

See Also

• [Notch Signaling](/mechanisms/notch-signaling)
• [Neurogenesis](/mechanisms/neurogenesis)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [Alzheimer's Disease](/diseases/alzheimers-disease)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving DLK1 Gene discovered through SciDEX knowledge graph analysis: